Interpretation on Chinese Expert Consensus of Irritable Bowel Syndrome in 2020

doi:10.3969/j.issn.1004-583X.2021.07.011

Abstract

Abstract:

Irritable bowel syndrome(IBS), as a common chronic disease in clinic, has obtained deep understanding constantly updated in recent years. In the second half of 2020, the Study Group of Gastrointestinal Functional Disorders of Chinese Society of Gastroenterology called on many domestic experts to formulate Chinese Expert Consensus of Irritable Bowel Syndrome in 2020. Based on 2015 consensus, this consensus improved and updated the definitions on etiology, epidemiology, pathogenesis, diagnoses and treatments of IBS. This paper interpreted the consensus in order to better guide the basic research and clinical diagnosis and treatment of IBS.

Key words: irritable bowel syndrome, diagnosis, treatment, expert consensus

CLC Number:

R574.62

Song Yiran, Liang Xiaonan, Li Chenyang, Zhang Xiaolan. Interpretation on Chinese Expert Consensus of Irritable Bowel Syndrome in 2020[J]. Clinical Focus, 2021, 36(7): 628-631.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.07.011

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I7/628

References 14

[1]	熊理守, 时权, 龚晓蓉, 等. 消化专科门诊肠易激综合征患者123例的临床特征与就医情况调查[J]. 中华消化杂志, 2015, (7):476-477.
[2]	中华医学会消化病学分会胃肠功能性疾病协作组, 中华医学会消化病学分会胃肠动力学组. 2020年中国肠易激综合征专家共识意见[J]. 中华消化杂志. 2020,12(40):803-818.
[3]	Gwee KA, Gonlachanvit S, Ghoshal UC, et al. Second Asian consensus on irritable bowel syndrome[J]. J Neurogastroenterol Motil, 2019,25(3):343-362. doi: 10.5056/jnm19041 URL
[4]	Mearin F, Lacy BE, Chang L, et al. Bowel disorders[J]. Gastroenterology, 2016,150(6):1393-1407. doi: 10.1053/j.gastro.2016.02.031 URL
[5]	Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020,17(8):473-486. doi: 10.1038/s41575-020-0286-8 URL
[6]	Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2020,5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X URL
[7]	Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling[J]. Aliment Pharmacol Ther, 2004,19(11):1217-1224. doi: 10.1111/apt.2004.19.issue-11 URL
[8]	DuPont AW, Jiang ZD, Harold SA, et al. Motility abnormalities in irritable bowel syndrome[J]. Digestion, 2014,89(2):119-123. doi: 10.1159/000356314 URL
[9]	Zhang J, Song L, Wang Y, et al. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats[J]. J Gastroenterol Hepatol, 2019,34(8):1368-1376. doi: 10.1111/jgh.v34.8 URL
[10]	Bai T, Xia J, Jiang Y, et al. Comparison of the Rome Ⅳ and Rome Ⅲ criteria for IBS diagnosis: A cross-sectional survey[J]. J Gastroenterol Hepatol, 2017,32(5):1018-1025. doi: 10.1111/jgh.13642 URL
[11]	Wang B, Zhao W, Zhao C, et al. What impact do Rome Ⅳ criteria have on patients with IBS in China?[J]. Scand J Gastroenterol, 2019,54(12):1433-1440. doi: 10.1080/00365521.2019.1698650 URL
[12]	Black CJ, Burr NE, Quigley EMM, et al. Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: Systematic review and network meta-analysis[J]. Gastroenterology, 2018,155(6):1753-1763. doi: 10.1053/j.gastro.2018.08.021 URL
[13]	Zheng L, Lai Y, Lu W, et al. Pinaverium reduces symptoms of irritable bowel syndrome in a multicenter, randomized, controlled trial[J]. Clin Gastroenterol Hepatol, 2015,13(7):1285-1292 e1281. doi: 10.1016/j.cgh.2015.01.015 URL
[14]	Black CJ, Thakur ER, Houghton LA, et al. Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis[J]. Gut, 2020,69(8):1441-1451. doi: 10.1136/gutjnl-2020-321191 URL

[1]	Chen Congshui, Li Yuan, Chen Shufang. Concerning the diagnosis and integrated Chinese and Western medicine treatment of acute biliary pancreatitis in children: A case report [J]. Clinical Focus, 2023, 38(8): 726-730.
[2]	Zhao Yanan, Wang Li, Li Xiaolei. Analysis of 2 children with kala-azar misdiagnosed as hemophagocytic syndrome [J]. Clinical Focus, 2023, 38(8): 722-725.
[3]	Gao Weikang, Quan Jianhua, Niu Xinrong. One case of missed diagnosis of multiple organ dysfunction syndrome complicated with adrenal crisis and literature review [J]. Clinical Focus, 2023, 38(4): 356-358.
[4]	Chai Chunyan, Wang ting. Clinical analysis of three elderly patients with hypercalcemia and literature review [J]. Clinical Focus, 2023, 38(2): 166-169.
[5]	Wang Siyuan, Wang Li, Wen Xinran, Li Xiaoqing. Multisystem inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection: Two cases report and literature review [J]. Clinical Focus, 2023, 38(12): 1112-1116.
[6]	Wang Junhong, Gao Zhenhua, Zhang Ronglong, Ji Haomin, Zhao Xinke, Da Mingxu. Quality analysis of the literatures associated with gastric cancer diagnosis from 1980-2021——A bibliometric analysis based on the Web of Science database [J]. Clinical Focus, 2023, 38(12): 1117-1124.
[7]	Luo Weigang, Xu Yuzhu, Zhang Lingyan, Wu Xiangyun, Bu Wei, Ren Huiling. Predictive value of the platelet function PFA-200 P2Y on the secondary prevention of acute ischemic stroke with clopidogrel [J]. Clinical Focus, 2023, 38(11): 979-983.
[8]	Wu Haotian, Fan Yuwen, Zhang Xiaolan. Guidelines for Diagnosis and Treatment of Chronic Gastritis in China (2022, Shanghai): An interpretation [J]. Clinical Focus, 2023, 38(10): 926-930.
[9]	Liu Ye, Ruan Guiren, Liu Xiaoqing, Shi Xiaochun, Fei Guijun. Diagnosis and differential diagnosis of pancreatic tuberculosis [J]. Clinical Focus, 2023, 38(10): 898-903.
[10]	Zhou Jingkun, Yang Caihong, Feng Tao, Cui Huaying. Diagnostic value of galactomannan on the comorbidity of bronchiectasis and pulmonary aspergillosis [J]. Clinical Focus, 2022, 37(9): 799-803.
[11]	Wang Zhenzhen, Zhao shiyi, Feng Siran, Ma Boqing. Predictive value of neutrophil to lymphocyte ratio for microalbuminuria of patients with type 2 diabetes mellitus [J]. Clinical Focus, 2022, 37(9): 808-812.
[12]	Wang Xiaoqing, Guo Yijia, Tang Yifang, Tang Qin, Yang Jie. The efficacy and safety of different blood pressure target on secondary stroke prevention: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 197-203.
[13]	Xu Jingran, Li Feifei, Xie Chengxin, Gong Hui, Luan Qiyun, Li Li. Application of endobronchial ultrasound transbronchial lung biopsy with guide sheath and rapid on-site evaluation in the diagnosis of bacteriologically-negative pulmonary tuberculosis [J]. Clinical Focus, 2022, 37(3): 220-224.
[14]	Yu Xin, Liu Zhongyang. Predictive value of lung ultrasonography on adjusted therapeutic regimen for patients with pneumonia [J]. Clinical Focus, 2022, 37(2): 133-136.
[15]	Chen Jie, Chen Shu, Yin Yufeng, Chang Xin, Wu Jian. Computed tomography values of lumbar spine in diagnosing osteoporosis: A meta-analysis [J]. Clinical Focus, 2022, 37(11): 970-976.